Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 874,837 | 450,712 | 331,412 | 270,827 | 157,170 |
| Cost of Goods | 19,075 | 12,269 | 4,481 | 6,408 | 7,229 |
| Gross Profit | 855,762 | 438,443 | 326,931 | 264,419 | 149,941 |
| Operating Expenses | 514,848 | 441,255 | 431,121 | 413,262 | 327,890 |
| Operating Income | 340,989 | -2,543 | -103,709 | -148,435 | -177,720 |
| Interest Expense | 78,872 | 98,516 | 108,239 | 99,092 | 59,294 |
| Other Income | 5,274 | 14,105 | -14,281 | 3,144 | 55,205 |
| Pre-tax Income | 267,391 | -86,954 | -226,229 | -244,383 | -181,809 |
| Income Tax | 3,530 | 1,927 | 310 | 2,733 | 2,253 |
| Net Income Continuous | 263,861 | -88,881 | -226,539 | -247,116 | -184,062 |
| Net Income | $263,861 | $-88,881 | $-226,539 | $-247,116 | $-184,062 |
| EPS Basic Total Ops | 1.26 | -0.43 | -1.18 | -1.33 | -1.03 |
| EPS Basic Continuous Ops | 1.26 | -0.43 | -1.18 | -1.33 | -1.03 |
| EPS Diluted Total Ops | 1.21 | -0.43 | -1.18 | -1.33 | -1.03 |
| EPS Diluted Continuous Ops | 1.21 | -0.43 | -1.18 | -1.33 | -1.03 |
| EPS Diluted Before Non-Recurring Items | 1.21 | -0.42 | -1.00 | -1.33 | -1.34 |
| EBITDA(a) | $338,047 | $-12,770 | $-112,317 | $-148,775 | $-176,945 |